• yl23455永利官网

    洞察市场格局
    解锁药品研发情报

    免费客服电话

    18983288589
    医药数据查询

    【ChiCTR2300068084】Effects of stand-alone mindfulness practices for people with long COVID-19 symptoms: A randomized controlled trial

    基本信息
    登记号

    ChiCTR2300068084

    试验状态

    尚未开始

    药物名称

    /

    药物类型

    /

    规范名称

    /

    首次公示信息日的期

    2023-02-06

    临床申请受理号

    /

    靶点

    /

    适应症

    Long COVID-19 symptoms

    试验通俗题目

    Effects of stand-alone mindfulness practices for people with long COVID-19 symptoms: A randomized controlled trial

    试验专业题目

    Effects of stand-alone mindfulness practices for people with long COVID-19 symptoms: A randomized controlled trial

    申办单位信息
    申请人联系人
    申请人名称
    联系人邮箱
    联系人邮编

    联系人通讯地址
    临床试验信息
    试验目的

    This study aims to evaluate the effects of mindfulness practices as a standalone intervention (an 8-week 1.25-hour online mindfulness practices class led by a mindfulness teacher, together with practice audios and a self-help booklet) among people with long COVID-19 symptoms, comparing to a health education control through a randomized controlled trial design. The primary objective is to: 1. Evaluate the effectiveness of the mindfulness practices in improving self-reported severity of long COVID-19 symptoms, functional disability, and overall health immediately after the 8-week intervention (primary time point) and 3 months after the intervention, comparing to the health education control. The secondary objectives are to: 2. Evaluate the effectiveness of the mindfulness practices in reducing proportions of participants having 1+, 3+, and 5+ symptoms in the intervention group immediately and 3 months after the 8-week intervention, compared to the control. 3. Evaluate the effectiveness of mindfulness practices in reducing depression, anxiety, health care utilization, and improving mindfulness and health-related quality of life immediately and 3 months after the intervention, compared to the control.

    试验分类
    试验类型

    随机平行对照

    试验分期

    其它

    随机化

    Computer-based simple randomization will be applied. The randomization procedure will be conducted by an independent statistician who is experienced in conducting randomization.

    盲法

    Participants will be asked not to disseminate the intervention contents during the study period to prevent contamination between the intervention and control groups. Due to the nature of the intervention, it is impossible to blind therapists and participants, but the investigators and persons who conduct the statistical analyses will be blinded to treatment allocation.

    试验项目经费来源

    Health and Medical Research Fund, Food and Health Bureau, HKSAR

    试验范围

    /

    目标入组人数

    165

    实际入组人数

    /

    第一例入组时间

    2023-02-06

    试验终止时间

    2025-02-05

    是否属于一致性

    /

    入选标准

    Inclusion criteria: 1. Aged 18 years or above, 2. With any self-reported long COVID-19 symptoms listed in the recent systematic review by Michelen and colleagues at least 3 months after tested positive for COVID-19, either through self-test or test in medical settings: (1) Systematic symptoms (fatigue, weakness, general malaise, dizziness); (2) Cardiopulmonary symptoms (breathlessness/dyspnoea, chest pain, cough, excessive sputum, others); (3) Upper respiratory symptoms (voice change, sore throat, nasal congestion, others), (4) Gastrointestinal symptoms (loss of appetite, stomach/abdominal discomfort/pain, weight loss, nausea or vomiting, diarrhoea, others); (5) Musculoskeletal symptoms (muscle pain/myalgia, joint pain/arthralgia, impaired mobility, others); (6) Neurological and neuromuscular symptoms (abnormal reflex status, smell disturbance, taste disturbance, decreased sensation or sensibility, tingling/ paraesthesia, others); (7) Neurocognitive symptoms (memory impairment, concentration impairment, frontal release signs, others), or others (hair loss, skin rash etc.) 3. No regular practice of mindfulness meditation.；

    排除标准

    Exclusion criteria: 1. Diagnosed psychiatric disorders, and suicidal ideation, plans, or behaviours, as they may need more intensive clinical care; 2. Recent bereavement or major loss; 3. Cannot understand Chinese as the programs will be conducted in Chinese; 4. Other conditions render them incapable of following the interventions.；

    研究者信息
    研究负责人姓名
    试验机构

    JC School of Public Health and Primary Care, The Chinese University of Hong Kong

    研究负责人电话
    研究负责人邮箱
    研究负责人邮编

    /

    联系人通讯地址

    最新临床资讯

    yl23455永利官网企业版
    50亿+条医药数据随时查
    7天免费试用
    体验产品